Home - Products - GPCR/G Protein - Bradykinin Receptor - Safotibant

Safotibant

CAS No. 633698-99-4

Safotibant( —— )

Catalog No. M34704 CAS No. 633698-99-4

Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	200	In Stock
10MG	302	In Stock
25MG	489	In Stock
50MG	658	In Stock
100MG	886	In Stock
200MG	1190	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Safotibant
Note

Research use only, not for human use.
Brief Description

Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.
Description

Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

GPCR/G Protein
Target

Bradykinin Receptor
Recptor

Bradykinin Receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

633698-99-4
Formula Weight

502.63
Molecular Formula

C25H34N4O5S
Purity

>98% (HPLC)
Solubility

——
SMILES

S(N(CCOCC(N(CC1=CC=C(C=C1)C=2NCCN2)C)=O)C)(=O)(=O)C3=C(C)C=C(OC)C=C3C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Sar-[D-Phe8]-des-Arg...

Potent and selective bradykinin B1 receptor agonist (EC50 = 9.02 nM in rabbit aorta) that is resistant to aminopeptidase, kininase I and II (ACE) and neutral endopeptidase cleavage. Exhibits hypotensive and angiogenic activity in vivo.
Bombinakinin M

Potent bradykinin receptor agonist. Highly selective for mammalian arterial smooth muscle bradykinin receptors, displaying ~ 50-fold greater potency than bradykinin. Elicits dose-dependent contractile effects in smooth muscle of guinea pig ileum (EC50 = 4.0 nM).
Anatibant 2HCl

Anatibant 2HCl is a small molecule bradykinin B2 receptor antagonist for the treatment of neurological disorders and may be used in the study of brain injury.

Sign In Join Free